Literature DB >> 1460184

Zinc status before and after zinc supplementation of eating disorder patients.

C J McClain1, M A Stuart, B Vivian, M McClain, R Talwalker, L Snelling, L Humphries.   

Abstract

Reduced food consumption is a major manifestation of zinc (Zn) deficiency. Many manifestations of Zn deficiency are complications of anorexia nervosa and bulimia nervosa. We evaluated serum and 24-hour urinary Zn values in 12 healthy volunteers and 33 eating disorder patients before and after hospitalization which included either Zn supplementation (75 mg Zn/day) or placebo. Bulimics had depressed serum Zn concentrations (p < 0.025). Admission urinary Zn was lower in bulimics (258 +/- 44 micrograms/day), and significantly depressed in anorexics (196 +/- 36 micrograms/day, p < 0.005) vs controls (376 +/- 45 micrograms/day). During hospitalization, serum Zn concentrations increased in all supplemented patients vs no change with placebo. Urinary Zn excretion increased in supplemented bulimics (p < 0.001) and placebo (p < 0.05). Urinary Zn excretion markedly increased in supplemented anorexics (179 +/- 65 to 1052 +/- 242 micrograms/day); however, placebo values fell or remained unacceptably low (admission 208 +/- 48 micrograms/day; discharge 160 +/- 17 micrograms/day). By dietary history, controls consumed the Recommended Dietary Allowance (RDA) for Zn (11.95 +/- 1.25 mg/day); anorexics 6.46 +/- 1.14 mg/day; and bulimics 8.93 +/- 1.29 mg/day. We suggest that Zn deficiency may act as a "sustaining" factor for abnormal eating behavior in certain eating disorder patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1460184     DOI: 10.1080/07315724.1992.10718269

Source DB:  PubMed          Journal:  J Am Coll Nutr        ISSN: 0731-5724            Impact factor:   3.169


  9 in total

Review 1.  Zinc supplementation in the treatment of anorexia nervosa.

Authors:  J C Su; C L Birmingham
Journal:  Eat Weight Disord       Date:  2002-03       Impact factor: 4.652

2.  How does zinc supplementation benefit anorexia nervosa?

Authors:  C L Birmingham; S Gritzner
Journal:  Eat Weight Disord       Date:  2006-12       Impact factor: 4.652

3.  Serum biochemical assessment of hepatic and renal functions of rats during oral exposure to glyphosate with zinc.

Authors:  Emmanuel Vandi Tizhe; Najume Dogon-Giginya Ibrahim; Mohammed Yakasai Fatihu; Ikechukwu Onyebuchi Igbokwe; Butcher-Danladi Jonathan George; Suleiman Folorunsho Ambali; Joshua Mallum Shallangwa
Journal:  Comp Clin Path       Date:  2013-05-03

4.  Reliability of the AccuSens Taste Kit(c) in patients with eating disorders.

Authors:  C Laird Birmingham; A Wong-Crowe; J Hlynsky; M Gao
Journal:  Eat Weight Disord       Date:  2005-06       Impact factor: 4.652

5.  Advances in the Treatment of Anorexia Nervosa and Bulimia Nervosa.

Authors:  S H Kennedy; D S Goldbloom
Journal:  CNS Drugs       Date:  1994-03       Impact factor: 5.749

6.  Reduced number of taste papillae in patients with eating disorders.

Authors:  L Wöckel; A Jacob; M Holtmann; F Poustka
Journal:  J Neural Transm (Vienna)       Date:  2008-02-04       Impact factor: 3.575

7.  Influence of zinc supplementation on histopathological changes in the stomach, liver, kidney, brain, pancreas and spleen during subchronic exposure of Wistar rats to glyphosate.

Authors:  Emmanuel Vandi Tizhe; Najume Dogon-Giginya Ibrahim; Mohammed Yakasai Fatihu; Igbokwe Ikechukwu Onyebuchi; Butcher Danladi Jonathan George; Suleiman Folorunsho Ambali; Joshua Mallum Shallangwa
Journal:  Comp Clin Path       Date:  2013-10-10

8.  Micronutrient Status in 153 Patients with Anorexia Nervosa.

Authors:  Najate Achamrah; Moïse Coëffier; Agnès Rimbert; Jocelyne Charles; Vanessa Folope; André Petit; Pierre Déchelotte; Sébastien Grigioni
Journal:  Nutrients       Date:  2017-03-02       Impact factor: 5.717

9.  Differences in serum zinc levels in acutely ill and remitted adolescents and young adults with bulimia nervosa in comparison with healthy controls - a cross-sectional pilot study.

Authors:  Florian D Zepf; Pradeep Rao; Kevin Runions; Richard M Stewart; Julia K Moore; Janice Wy Wong; Maike Linden; Idil Sungurtekin; Franziska Glass; Linda Gut; Dirk Peetz; Gudrun Hintereder; Michael Schaab; Fritz Poustka; Lars Wöckel
Journal:  Neuropsychiatr Dis Treat       Date:  2017-10-17       Impact factor: 2.570

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.